<DOC>
	<DOCNO>NCT02350361</DOCNO>
	<brief_summary>Here go find method use available multiple drug include angiogenesis medicine - Endostar treat lung cancer patient acquire resistence EGFR-TKI responsed .</brief_summary>
	<brief_title>Endostar Combination With Chemotherapy EGFR-TKI Lung Cancer Rechallenging Treatment After Acquired Resistance .</brief_title>
	<detailed_description>Lung cancer patient receive epidermal growth factor receptor tyrosine kinase inhibitor ( EGFR-TKI ) acquire resistance drug . This study use Endostar , angiogentic medicine , combination chemotherapy EGFR-TKI lung cancer rechallenging treatment resistance EGFR-TKI progression disease .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Endostatins</mesh_term>
	<criteria>Patients pathologic confirmation NSCLC tissue diagnosis cytologic diagnosis , whose NSCLCs locally advance metastatic Stage IIIB / IV adenocarcinoma , inoperable incurable radiotherapy . Life expectancy least three ( 3 ) month start administration investigational drug . Eastern Cooperative Oncology Group ( ECOG ) performance Score 0 2 . Patients least one tumor lesion accurately measure CT MRI least one dimension long diameter record less double slice thickness &gt; =10 mm . Patient receive least 6 month EGFRTKI show tumor progress Adequate hematologic hepatic renal function base normal condition chemotherapy Patient sign consent form adherence geographic location liable follow CNS metastasis Active infection Bleeding tendency blood coagulation dysfunction History neurological psychiatric disorder , include epilepsy , dementia Pregnancy breastfeed woman Organ transplant longterm use immunosuppressive drug Arrhythmia need antiarrhythmic treatment risk heart disease Use target drug research Other condition may allow join study accord researcher 's judgment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>endostar</keyword>
	<keyword>angiogenesis</keyword>
	<keyword>EGFR-TKI</keyword>
	<keyword>lung caner</keyword>
</DOC>